U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07214272) titled 'A Phase 4 Clinical Study to Investigate the Effectiveness and Safety of Skin Resurfacing' on Sept. 18.
Brief Summary: This study is a prospective, post-marketing (Phase 4) non-registrational single-arm, open-label, multicenter study.
Study Start Date: Oct., 2025
Study Type: INTERVENTIONAL
Condition:
Skin Resurfacing
Intervention:
DEVICE: Fraxel(R) FTX Laser System
The Fraxel Laser System has two fiber-laser sources that are contained in a single Console. The Console is electrically connected to the facility power source. Laser energy produced by the unit is delivered to the tissue through the Handpiece, which is connected to ...